Apalutamide for high-risk localized prostate cancer following radical prostatectomy- A new Horizon

Apalutamide for high-risk localized prostate cancer following radical prostatectomy- A new Horizon

Saved in:

Bibliographic Details
Main Author:	Mithilesh Yadav
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Indian Journal of Urology
Online Access:	https://journals.lww.com/10.4103/iju.iju_96_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sexuality of prostate cancer patients following radical prostatectomy
by: M. E. Efremov, et al.
Published: (2025-06-01)

Robot-Assisted Radical Prostatectomy in High-Risk Prostate Cancer
by: V. N. Pavlov, et al.
Published: (2021-12-01)

Radical Prostatectomy and Intraoperative Radiation Therapy in High-Risk Prostate Cancer
by: Giansilvio Marchioro, et al.
Published: (2012-01-01)

The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer
by: Barış Kuzgunbay, et al.
Published: (2015-09-01)

Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
by: Peerapon Sangthong, et al.
Published: (2025-07-01)

RADICAL PROSTATECTOMY AND ROBOTIC RADIOSURGERY AS TREATMENT OPTIONS FOR LOCALIZED PROSTATE CANCER
by: E. A. Kipriyanov, et al.
Published: (2020-03-01)

Age-Specific Impact of Cribriform Pattern in Prostate Cancer Following Radical Prostatectomy
by: Ari S Hilibrand, et al.
Published: (2025-08-01)

Prognostic Significance of Lymphovascular Invasion in Clinically Localized Prostate Cancer after Radical Prostatectomy
by: Dilek Ertoy Baydar, et al.
Published: (2008-01-01)

Prognostic value of pathological sensitivity for high-risk, localized prostate cancer receiving neoadjuvant hormonal therapy combined with radical prostatectomy
by: Kai Shi, et al.
Published: (2025-12-01)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
by: Parth Patel, et al.
Published: (2015-01-01)

IMPACT OF PREOPERATIVE STAGING OF PROSTATIC CANCER ON POSITIVE SURGICAL MARGIN INCIDENCE FOLLOWING RADICAL PROSTATECTOMY
by: V. L. Medvedev, et al.
Published: (2019-02-01)

A retrospective study of neoadjuvant novel hormonal therapy prior to radical prostatectomy for high-risk prostate cancer
by: Hui Shuai, et al.
Published: (2025-02-01)

Prostate Imaging Reporting and Data System in prostate cancer staging and planning for radical prostatectomy
by: Mieszko Kozikowski, et al.
Published: (2019-03-01)

DIAGNOSTIC CONSIDERATION OF RADIAL IMAGING METHODS IN IDENTIFYING LOCAL RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
by: E. A. Bezrukov, et al.
Published: (2015-09-01)

Prevalence and impact of sarcopenia on urinary incontinence in localized prostate cancer patients undergoing laparoscopic radical prostatectomy
by: Tengfei Gu, et al.
Published: (2025-04-01)

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer
by: Carolin Siech, et al.
Published: (2025-02-01)

Comparison of efficacy of Retzius-sparing radical prostatectomy versus standard radical prostatectomy in the treatment of prostate cancer: a systematic review and meta-analysis
by: Weilun Gong, et al.
Published: (2025-05-01)

Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy
by: Hyun Jung Lee, et al.
Published: (2025-03-01)

Unfavorable low-risk factors predict pathologic upstaging and upgrading following radical prostatectomy: Evidence for further subclassification of low-risk prostate cancer?
by: Magdelinić Aleksandar, et al.
Published: (2025-01-01)

Comparison of Transperineal Mapping Biopsy Results with Whole-Mount Radical Prostatectomy Pathology in Patients with Localized Prostate Cancer
by: Darren J. Katz, et al.
Published: (2014-01-01)

Distant ureteric metastasis of prostate cancer four years post radical prostatectomy
by: Sachin J. Joshi, et al.
Published: (2025-03-01)

Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide
by: Qi Wang, et al.
Published: (2025-02-01)

Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer
by: Juan A. Encarnación Navarro, et al.
Published: (2025-02-01)

Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
by: Natalia Gorbokon, et al.
Published: (2025-09-01)

Robotic Radical Prostatectomy in Patients with Previous Prostate Surgery and Radiotherapy
by: Ömer Acar, et al.
Published: (2014-01-01)

Biochemical Recurrence in High-Risk Localized Prostate Cancer: A Comparison of Laparoscopic Prostatectomy and External Radiotherapy
by: Lubos Rybar, et al.
Published: (2025-05-01)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
by: Christa Babst, et al.
Published: (2022-01-01)

Clinical efficacy of cytoreductive radical prostatectomy in the treatment of oligometastatic hormone-sensitive prostate cancer
by: Feng Qi, et al.
Published: (2025-01-01)

Robot-Assisted Laparoscopic Radical Prostatectomy for Prostatic Metastatic Recurrence from Testicular Cancer
by: Kohei Hirose, et al.
Published: (2024-01-01)

Prognostic significance of the logistic regression model for assessing the risk of recurrence in patients with prostate cancer after radical prostatectomy
by: S. A. Reva, et al.
Published: (2022-12-01)

Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
by: Saizo Fujmoto, et al.
Published: (2023-02-01)

Liquid chromatography–tandem mass spectrometry assay for the simultaneous determination of apalutamide and its active metabolite N-desmethyl apalutamide, and its application in real-world patients with castration-resistant prostate cancer
by: Yuxuan Zhu, et al.
Published: (2025-05-01)

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer
by: Mike Wenzel, et al.
Published: (2025-07-01)

A 5-Year Follow-Up of Patient-Reported Outcome Measures Following External Beam Radiotherapy or Radical Prostatectomy in Localised Prostate Cancer
by: Rowan V. David, et al.
Published: (2025-04-01)

Salvage Versus Adjuvant Radiation Therapy Following Radical Prostatectomy in Localised Prostate Cancer: A War Without a Winner
by: Lara Rodriguez-Sanchez, et al.
Published: (2023-01-01)

A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical Prostatectomy
by: Makoto Kawase, et al.
Published: (2021-01-01)

REHABILITATION EFFECT OF CORRECTION OF ERECTILE DYSFUNCTION IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY FOR PROSTATE CANCER
by: A. T. Asratov, et al.
Published: (2018-06-01)

The Prostate cancer–Exercise and Metformin randomised controlled feasibility Trial (Pre-EMpT) in men following active surveillance, radical prostatectomy and radiotherapy
by: Luke A. Robles, et al.
Published: (2025-05-01)

Laparoscopic radical prostatectomy
by: V. A. Perepechay, et al.
Published: (2018-10-01)

14 PSA based intermediate endpoints to compare cancer specific survival difference between radiotherapy and radical prostatectomy for the treatment of localized prostate cancer
by: P. Wiklund, et al.
Published: (2025-01-01)